Constant Therapy
operating company Β· company profileNewton Β· 1 people tracked
Investment thesis
Millions suffer from chronic neurological conditions that could improve through extended therapy, yet access is limited by insurance coverage and clinician shortages. Constant Therapy combines large-scale data and AI to deliver personalized, remote therapy that standardizes care delivery, reduces costs compared to in-clinic sessions, and improves patient outcomes by enabling more frequent practice. The platform collects real-world evidence to enhance recovery protocols and advance understanding of brain plasticity and rehabilitation.
Source: firm website, verified Aug 6, 2026.
Team Β· 1 people
from public directoriesFrequently asked questions
- What sectors does Constant Therapy focus on?
- Constant Therapy focuses on AI & Machine Learning, Digital Health, Healthtech.
- Where is Constant Therapy located?
- Constant Therapy is headquartered in Newton, US.
Images
Co-investors Β· 1
XFactor Ventures is an early-stage venture firm affiliated with the broader Flybridge community, giving portfolio founders access to a network of founders, builders, and mentors.
Firms observed investing alongside Constant Therapy, from public investor directories. Shared companies are the overlap with Constant Therapy's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Hyderabad Angels is an angel investor network founded in 2010, comprising entrepreneurs, industrialists, and family offices that back early-stage startups across India with capital, mentorship, and strategic networks.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.


